Cargando…

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum

Visceral leishmaniasis (VL), a vector-borne parasitic disease caused by Leishmania donovani and L. infantum (Kinetoplastida), affects humans and dogs, being fatal unless treated. Miltefosine (MIL) is the only oral medication for VL and is considered a first choice drug when resistance to antimonials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olías-Molero, Ana Isabel, Botías, Pedro, Cuquerella, Montserrat, García-Cantalejo, Jesús, Barcia, Emilia, Torrado, Susana, Torrado, Juan José, Alunda, José María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952363/ https://www.ncbi.nlm.nih.gov/pubmed/36830274 http://dx.doi.org/10.3390/antibiotics12020362

Ejemplares similares

Leishmania infantum infection does not affect the main composition of the intestinal microbiome of the Syrian hamster
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2022)

Antileishmanial Drug Discovery and Development: Time to Reset the Model?
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2021)

In-Vitro Activity of Silybin and Related Flavonolignans against Leishmania infantum and L. donovani
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2018)

Efficient infection of hamster with Leishmania donovani by retro-orbital inoculation
por: Jiménez-Antón, M. D., et al.
Publicado: (2019)

Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging
por: Reimão, Juliana Q., et al.
Publicado: (2015)

Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
por: Vincent, Isabel M., et al.
Publicado: (2015)

Infection of dogs by Leishmania infantum elicits a general response of IgG subclasses
por: Olías-Molero, A. I., et al.
Publicado: (2020)

Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure
por: Hendrickx, S., et al.
Publicado: (2018)

New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates
por: Bhattacharya, Arijit, et al.
Publicado: (2018)

Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol
por: Gonçalves, Gustavo, et al.
Publicado: (2021)

Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition
por: Bulté, Dimitri, et al.
Publicado: (2021)

Scientometric analysis of chemotherapy of canine leishmaniasis (2000–2020)
por: Olías-Molero, A. I., et al.
Publicado: (2021)

Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
por: dos Santos Nogueira, Fabio, et al.
Publicado: (2019)

In-Depth Quantitative Proteomics Characterization of In Vitro Selected Miltefosine Resistance in Leishmania infantum
por: Saboia-Vahia, Leonardo, et al.
Publicado: (2022)

3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine
por: Carnielli, Juliana B.T., et al.
Publicado: (2022)

Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches
por: Rebello, Karina M., et al.
Publicado: (2019)

A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
por: Carnielli, Juliana B.T., et al.
Publicado: (2018)

Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
por: Hendrickx, Sarah, et al.
Publicado: (2017)

Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
por: Van Bockstal, Lieselotte, et al.
Publicado: (2020)

Resolution of tongue lesions caused by Leishmania infantum in a dog treated with the association miltefosine-allopurinol
por: Foglia Manzillo, Valentina, et al.
Publicado: (2009)

Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism()
por: Vincent, Isabel M., et al.
Publicado: (2013)

Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil
por: Carnielli, Juliana B. T., et al.
Publicado: (2019)

Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility
por: Santi, Ana Maria Murta, et al.
Publicado: (2021)

Vaccination with Leishmania infantum Acidic Ribosomal P0 but Not with Nucleosomal Histones Proteins Controls Leishmania infantum Infection in Hamsters
por: Pereira, Lais, et al.
Publicado: (2015)

In Vitro Susceptibility to Miltefosine of Leishmania infantum (syn. L. chagasi) Isolates from Different Geographical Areas in Brazil
por: Espada, Caroline Ricce, et al.
Publicado: (2021)

Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis
por: Van Bockstal, Lieselotte, et al.
Publicado: (2019)

Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose
por: González-Sánchez, María Elena, et al.
Publicado: (2018)

Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity
por: Castelo-Branco, Patrícia Valéria, et al.
Publicado: (2018)

Leishmania Resistance to Miltefosine Associated with Genetic Marker
por: Cojean, Sandrine, et al.
Publicado: (2012)

Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
por: Mondelaers, Annelies, et al.
Publicado: (2016)

Immunization with recombinant rHc23 partially protects lambs against trickle infections by Haemonchus contortus
por: González-Sánchez, María Elena, et al.
Publicado: (2019)

Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major
por: Turner, Kimbra G., et al.
Publicado: (2015)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
por: Sadowsky, Rachel L., et al.
Publicado: (2022)

Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis
por: Ferreira, Carolina, et al.
Publicado: (2020)

The Gut Microbiome of the Vector Lutzomyia longipalpis Is Essential for Survival of Leishmania infantum
por: Kelly, Patrick H., et al.
Publicado: (2017)

Early antibody response and clinical outcome in experimental canine leishmaniasis
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2019)

Parasite Burden in Hamsters Infected with Two Different Strains of Leishmania (Leishmania) infantum: “Leishman Donovan Units” versus Real-Time PCR
por: Moreira, Nádia das Dores, et al.
Publicado: (2012)

New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
por: González, Myriam, et al.
Publicado: (2021)

Increased levels of cortisol are associated with the severity of experimental visceral leishmaniasis in a Leishmania (L.) infantum-hamster model
por: Barros-Gonçalves, Tayany de D., et al.
Publicado: (2021)

Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB
por: Pérez-Pertejo, Yolanda, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a9094k3sut0vekjvmml6n7c0j0